Heart Failure News and Research

RSS
Heart failure (HF) is a condition in which a problem with the structure or function of the heart impairs its ability to supply sufficient blood flow to meet the body's needs. It should not be confused with cardiac arrest or myocardial infarction.
MRI method to map creatine in heart may help detect disorders earlier than traditional methods

MRI method to map creatine in heart may help detect disorders earlier than traditional methods

Obesity interferes with blood pressure control

Obesity interferes with blood pressure control

Sutter Davis Hospital receives Malcolm Baldrige National Quality Award for excellent performance

Sutter Davis Hospital receives Malcolm Baldrige National Quality Award for excellent performance

Trevena doses first patient in TRV027 Phase 2b trial for acute heart failure

Trevena doses first patient in TRV027 Phase 2b trial for acute heart failure

GSK receives FDA approval for combination of Mekinist with Tafinlar for treatment of melanoma

GSK receives FDA approval for combination of Mekinist with Tafinlar for treatment of melanoma

Hospitals with higher rates of readmissions may suffer cut in Medicare payments by 2015

Hospitals with higher rates of readmissions may suffer cut in Medicare payments by 2015

Research opens door to new direction of PAH treatment

Research opens door to new direction of PAH treatment

Barostim Therapy: A cost-effective treatment for patients with drug resistant hypertension

Barostim Therapy: A cost-effective treatment for patients with drug resistant hypertension

FDA OOPD grants orphan drug designation to Alitair's Erdosteine for treatment of bronchiectasis

FDA OOPD grants orphan drug designation to Alitair's Erdosteine for treatment of bronchiectasis

EC grants approval for ABRAXANE in combination with gemcitabine for metastatic pancreatic cancer

EC grants approval for ABRAXANE in combination with gemcitabine for metastatic pancreatic cancer

Oxygen Biotherapeutics announces publication of Phase 3 trial protocol for levosimendan

Oxygen Biotherapeutics announces publication of Phase 3 trial protocol for levosimendan

Apple Valley Medical Clinic Sleep Center moves to 14843 Energy Way in Apple Valley

Apple Valley Medical Clinic Sleep Center moves to 14843 Energy Way in Apple Valley

Personalized asthma strategies needed to tackle comorbidities

Personalized asthma strategies needed to tackle comorbidities

Cardio3 BioSciences to participate in forthcoming Annual JP Morgan Healthcare Conference

Cardio3 BioSciences to participate in forthcoming Annual JP Morgan Healthcare Conference

Ikaria shareholders to sell Commercial Business to Madison Dearborn Partners

Ikaria shareholders to sell Commercial Business to Madison Dearborn Partners

Researchers report new gene delivery method that targets tumor blood vessels

Researchers report new gene delivery method that targets tumor blood vessels

Most frequent reasons for readmission often related to patients' underlying chronic medical conditions

Most frequent reasons for readmission often related to patients' underlying chronic medical conditions

Intrexon enters into definitive agreement to acquire Medistem

Intrexon enters into definitive agreement to acquire Medistem

Texas Children's Hospital recognized as first Accredited Pediatric Heart Failure Institute in Texas

Texas Children's Hospital recognized as first Accredited Pediatric Heart Failure Institute in Texas

UC San Diego Sulpizio listed in “100 Hospitals with Great Heart Programs”

UC San Diego Sulpizio listed in “100 Hospitals with Great Heart Programs”

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.